The global Biomaterials Market reached USD 237.0 billion in 2025 and is projected to grow to USD 836.5 billion by 2033, representing a CAGR of 17.3% from 2026 to 2033. North America held the largest revenue share at 38.1% in 2025, while Asia Pacific is projected to experience the fastest growth.

The increasing incidence of musculoskeletal and chronic skeletal conditions is supporting demand for implants based on biomaterials. At the same time, advances in minimally invasive surgery, regenerative medicine, and multifunctional materials are broadening applications across healthcare.

A Material Shift in Modern Healthcare

Biomaterials are becoming increasingly important as healthcare moves toward more advanced surgical and implantable solutions. Metallic materials accounted for the largest product share, representing 40.6% of revenue in 2025.

Their mechanical strength, biocompatibility, and corrosion resistance make them particularly suitable for load-bearing applications. Orthopedic procedures use metallic biomaterials for wires, screws, fixation plates, and artificial joints.

Download a free sample copy of the Biomaterials Market report to understand detailed coverage and inclusions in the final report

Natural biomaterials are also attracting attention because of their biodegradability, biocompatibility, and ability to support tissue remodeling.

Orthopedics Remains the Largest Application

Orthopedic applications generated the largest revenue share of 24.9% in 2025. The widespread use of metallic biomaterials in load-bearing orthopedic implants is a major contributor to this position.

The growing prevalence of musculoskeletal disorders and continued development of advanced implants are supporting demand.

Plastic surgery, meanwhile, is projected to record the fastest growth. Demand for cosmetic and reconstructive procedures, combined with improvements in durable and customizable biomaterials, is supporting expansion.

Technology Is Expanding the Role of Biomaterials

The industry is experiencing rapid innovation in bioactive materials, nanotechnology-enabled coatings, bioresorbable polymers, and multifunctional composites.

Advanced biomaterials are being developed to improve antimicrobial performance, tissue interaction, and regenerative potential. Titanium implants functionalized with manganese-doped zinc oxide nanoparticles represent one example of research focused on combining antibacterial properties with tissue regeneration.

Additive manufacturing and precision surface engineering are also improving customization and scalability.

Regional Growth Has a Clear Leader

North America represented 38.1% of global revenue in 2025. Advanced healthcare infrastructure, high R&D investment, innovative surgical technologies, and the presence of leading companies support its leadership.

Looking for more specific insights? Customize this report to suite your business needs

The U.S. market is benefiting from demand for orthopedic, cardiovascular, and dental implants, alongside increasing adoption of minimally invasive and regenerative procedures.

Europe is supported by advanced healthcare infrastructure and demand for orthopedic and dental implants. The UK and Germany are experiencing growth through surgical innovation, R&D investment, and adoption of bioresorbable and multifunctional materials.

Asia Pacific is the fastest-growing region, with a projected CAGR of 18.8%. China, India, and Japan are benefiting from expanding healthcare infrastructure, chronic disease prevalence, medical tourism, and government initiatives supporting healthcare innovation.

The Middle East and Africa are also expanding as healthcare infrastructure develops and demand for advanced implants increases. Kuwait represents one of the markets contributing to this regional development.

Cost and Regulation Remain Important Considerations

High development and manufacturing costs remain a challenge. Biomaterials must meet demanding safety, efficacy, and biocompatibility requirements, while regulatory processes can extend commercialization timelines.

Despite these challenges, companies are expanding product portfolios, entering emerging markets, and investing in regenerative medicine and minimally invasive technologies.

Competition Is Driven by Innovation

The market includes established companies and emerging specialists. Merck KGaA, Sartorius Stedim Biotech, and Berkeley Lights are among the companies discussed in the provided market content, while Medtronic, Evonik Industries AG, Zimmer Biomet Holdings, BASF SE, and Covalon Technologies Ltd. are among the key companies profiled.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Strategic collaborations, acquisitions, product expansion, and geographic diversification are shaping competition.

The Next Stage of Biomaterials Growth

The market's development is increasingly connected with personalized implants, regenerative medicine, advanced surgery, and multifunctional materials. As healthcare systems adopt more sophisticated procedures, biomaterials are expected to play a broader role across orthopedic, cardiovascular, dental, plastic surgery, and regenerative applications.

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.